Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/2003
05/01/2003US20030083336 Dopamine D4 receptor ligands; treating psychosis, schizophrenia and affective disorders
05/01/2003US20030083333 1,4-Disubstituted benzo-fused compounds
05/01/2003US20030083332 N-heterocyclic derivatives as NOS inhibitors
05/01/2003US20030083325 Serotonin antagonists
05/01/2003US20030083298 Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis or growth of DMS
05/01/2003US20030083294 Enhancing or inhibiting the biological activity of nucleic acid ligands by administrating a modulator, to change the binding of the nucleic acid ligand for its target or degrading or cleaving
05/01/2003US20030083286 Comprises penetration enhancer (fatty acid); drug delivery; increases bioavailability of oligonucleotides
05/01/2003US20030083272 Sense mrna therapy
05/01/2003US20030083256 Compositions and methods for enhancing drug delivery across and into epithelial tissues
05/01/2003US20030083254 Heparanase-like proteins and nucleotides that encode them
05/01/2003US20030083252 Neuronal uses of BMP-11
05/01/2003US20030083246 Methods for treating rheumatic diseases using a soluble CTLA4 molecule
05/01/2003US20030083242 Methods and compositions for treating or preventing peripheral neuropathies
05/01/2003US20030083239 Hexapeptide capable of inhibiting beta-chemokine from binding to CCR3 receptor; for treating subject with a disease associated with aberrant leukocyte recruitment and/or activation
05/01/2003US20030082793 Method for preparation of physiologically active water-base extract and method for potentiating the activity thereof
05/01/2003US20030082725 DNA encoding a novel human inhibitor-of-apoptosis protein
05/01/2003US20030082672 Dna encoding galanin galr2 receptors and uses thereof
05/01/2003US20030082643 Human monoclonal antibodies to FC alpha receptor (CD89)
05/01/2003US20030082554 Nucleotide sequences coding polypeptide for use in the treatment of immunlological, thyroid, metabolic, bone and pancreatic disorders
05/01/2003US20030082238 Matrices for drug delivery and methods for making and using the same
05/01/2003US20030082225 Sterile, breathable patch for treating wound pain
05/01/2003US20030082214 Oil in water emulsion containing antidepressant, anesthetics
05/01/2003US20030082207 Method of using HIV protease inhibiting compounds
05/01/2003US20030082191 Treatment for central nervous system disorders
05/01/2003US20030082190 Fusion molecules and treatment of IgE-mediated allergic diseases
05/01/2003US20030082180 Combination of compounds that inhibit the biological effects of tnf-alpha and cd95l in a medicament
05/01/2003US20030082166 Compounds and methods for modulating nonclassical cadherin-mediated functions
05/01/2003US20030082160 Differentiation of whole bone marrow
05/01/2003US20030082142 Replication incompetent herpes viruses for use in gene therapy
05/01/2003US20030082135 Pathway of RANTES-mediated chemokine synthesis in astrocytes and methods of use therefor
05/01/2003CA2466813A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors
05/01/2003CA2464981A1 Quinoline compound
05/01/2003CA2464695A1 Il-13 mutein proteins, antibodies, compositions, methods and uses
05/01/2003CA2464593A1 6-hydroxy isoflavones, derivatives and medicaments involving same
05/01/2003CA2464344A1 Ee3-protein family and corresponding dna sequences
05/01/2003CA2464085A1 A combination product comprising melagatran and dexamethasone
05/01/2003CA2463951A1 Solid pharmaceutical formulation for a piperazine urea derivative
05/01/2003CA2463923A1 Novel hydroxyalkyl indolocarbazole derivatives, preparation method and pharmaceutical compositions containing same
05/01/2003CA2463309A1 Sterile, breathable patch for treating wound pain
05/01/2003CA2463101A1 Azole derivatives and pharmaceutical compositions containing them
05/01/2003CA2461543A1 Sperm factor sequences
05/01/2003CA2461159A1 Imidazopyridine compounds as 5-ht4 receptor modulators
05/01/2003CA2458958A1 Method and apparatus for dispensing inhalator medicament
04/2003
04/30/2003CN1415074A Method of detection of amyloidogenic proteins
04/30/2003CN1414976A Chimeric peptides used as immunogen and its antibody, and method for their use for immunization
04/30/2003CN1414963A Novel heteroary derivatives, their preparation and use
04/30/2003CN1414962A [(Indol-3-yl)-cycloalkyl]-3-substituted azetidines for treatment of central nervous system disorders
04/30/2003CN1414961A Substituted oximes and hydrazones as neurokinin antagonists
04/30/2003CN1414960A Substituted piperidines, medicaments containing these compounds, and methods for production thereof
04/30/2003CN1414958A Nonpeptide substituted benzothiazepines as vasopressin antagonists
04/30/2003CN1414953A Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and 5-hydroxytryptamine
04/30/2003CN1414950A Substituted pyrrole Mannich bases to treating paint and allergic reactions
04/30/2003CN1414946A Novel esters derived from (RR,SS)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxy cyclohexyl) phenyl
04/30/2003CN1414864A Adhesive particle DNA constructs and method of making and using the same
04/30/2003CN1414853A Oral mucosal dosage forms of apomorphine
04/30/2003CN1414851A Method and formulation for treating resistance to antihypertensives and related conditions
04/30/2003CN1413724A Brain active effect matter for prevention and curing encephalopathy and developing intelligence and its preparation method
04/30/2003CN1413723A Method for extracting medicine from bluish dogbane
04/30/2003CN1413718A Chinese medicinal powder for treating headache
04/30/2003CN1413709A Traditional Chinese medicine of grinding, mixing and drying for added with other Chinese patent drug
04/30/2003CN1413704A Huafeng pill
04/30/2003CN1413656A Weinakang for treating ischemic cerebrovascular disease and senile dementia and its preparation method
04/30/2003CN1413645A Composite medicine for treating lumbodynia and method for preparing medicinal cup thereof
04/30/2003CN1413643A Method for extracting chrysanthemum medicinal component and extract
04/30/2003CN1413589A Composition of paeoniflorin and albiflorin and its preparation method
04/30/2003CN1413587A Application of ganglioside in preparation of antiepileptic
04/30/2003CN1107066C Diaza-spiro [3,5] nonane derivatives
04/30/2003CN1107058C Subsitituted isoxazoles for treatment of inflammation
04/30/2003CN1106853C Capsule for treating epilepsy
04/29/2003US6555700 1,3-propane diol esters and ethers and methods for their use in drug delivery
04/29/2003US6555684 Pyrimidinyl compounds for treatment of central nervous system disorders
04/29/2003US6555665 Glycosidation of 4,5-epoxymorphinan-6-ols
04/29/2003US6555651 Ligand binding site of rage and uses thereof
04/29/2003US6555586 Treating obesity, anxiety disorder, post-traumatic stress disorder, premenstrual syndrome, attention deficit disorder, Tourette syndrome, bulimia nervosa or Shy Drager Syndrome by administering a hydroxycycloalkanephenethyl amine
04/29/2003US6555585 For decreasing amphetamine-induced hyperactivity
04/29/2003US6555575 Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of disease
04/29/2003US6555560 Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene
04/29/2003US6555550 Musarinic agonists and antagonists
04/29/2003US6555544 9-hydroxyrisperidone palmitate ester having a surfactant adsorbed to the surface thereof; for administration via intramuscular or subcutaneous injection; treating psychological and neurodegenerative disorders
04/29/2003US6555542 Sulfonamide lactam inhibitors of FXa and method
04/29/2003US6555540 Combinations of aldose reductase inhibitors and selective cyclooxygenase-2 inhibitors
04/29/2003US6555519 O-glucosylated benzamide SGLT2 inhibitors and method
04/29/2003US6555518 2',2'-difluoronucleosides for suppressing rejection of transplants in mammals; for treatment of autoimmune diseases
04/29/2003US6555377 Process for production of mammalian cell lines
04/29/2003US6555341 Gamma-aminobutyric acid (GABA); stably co-transfected eukaryotic cell line capable of expressing a human GABAa receptor which comprises a theta receptor subunit and at least one receptor subunit; drug screening
04/29/2003US6555136 Pharmaceutical dosage form for pulsatile delivery of methylphenidate
04/29/2003US6555109 Non-toxic fraction isolated from the venom of Vipera xanthina
04/29/2003CA2123160C Controlled release formulation
04/29/2003CA2105804C Kainate-binding, human cns receptors of the eaa5 family
04/29/2003CA2078028C A tramadol n-oxide material, enantiomers and compositions thereof, and their use
04/25/2003CA2409910A1 Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
04/24/2003WO2003034275A2 Chimeric glycosylphosphatidylinositol containing peptides
04/24/2003WO2003033720A2 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
04/24/2003WO2003033680A2 Kinases and phosphatases
04/24/2003WO2003033671A2 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
04/24/2003WO2003033535A2 Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
04/24/2003WO2003033528A1 Cyclic peptides as g-protein-coupled receptor antagonists
04/24/2003WO2003033527A2 Cyclosporine analogue mixtures and their use as immunomodulating agents
04/24/2003WO2003033524A2 Peptidyl ketones as inhibitors of dpiv
04/24/2003WO2003033518A1 Steroidal compounds for inhibiting steroid sulphatase
1 ... 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 ... 1833